Moberg Pharma — Major Shareholding Notification 2015

Sep 30, 2015

Issuer Moberg Pharma AB (publ)

Holder

Kingdon Capital Management, L.L.C.

Instrument

Instrument	Common shares SE0003613090
Before the transaction
Shares	701,000
Voting rights	701,000
Transaction
Reason for major shareholding notification Sell
Date	29/09/2015
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	693,511
Directly held voting rights	0
Indirectly held voting rights	693,511
Percentage
Directly held shares	4.95 %
Directly held voting rights	0 %
Indirectly held voting rights	4.95 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares

Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3

• Physically settled
• Cash settled

Total

Chain of controlling companies

Voting rights % Voting rights Company 251,010 1.79 Kingdon Associates 386,944 2.76 M. Kingdon Offshore Master Fund L.P 55,557 0.4 Kingdon Family Partnership, L.P. Group total holdings

Voting rights 693,511

Percentage of voting rights 4.95

Published

30/09/2015 16:52 Contact

Name Dennis Bertron Phone +1 (212) 333-0100 Email legal@kingdon.com

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25